Anti-glomerular basement membrane (GBM) glomerulonephritis induced in WKY rats is characterized by glomerular accumulation of CD8 + T cells and monocytes/macrophages, followed by crescent formation. The mechanism of leukocyte accumulation after antibody binding to GBM is still unclear. To unveil an involvement of Fcg receptors (FcgR) in leukocytes recruitment we examined the expression of FcgR in glomeruli and the effects of the administration of F(ab¢) 2 fragment of anti-GBM antibody or FcgR blocking on the initiation and progression of this model. A gradual increase of FcgR mRNA expression in glomeruli during the time course of disease suggested their signi®cance in the development of glomerulonephritis. Glomerular lesions and proteinuria were induced only in rats injected with intact IgG of anti-GBM antibody, but not with the F(ab¢) 2 fragment. In vivo blocking of FcgR by administering heat-aggregated IgG led to the decrease of mRNA expression for all types of FcgR (types 1, 2 and 3) and a signi®cant amelioration of glomerulonephritis manifestations. By¯ow cytometry and immunohistochemistry FcgR2-expressing cells in glomeruli were identi®ed as macrophages, but not CD8 + T cells. The expression of FcgR1 and 3 was signi®cantly decreased, and that of FcgR2 became undetectable in CD8 + T celldepleted rats. Thus, CD8 + T cells may stimulate FcgR expression on macrophages, contributing to their glomerular accumulation and injury. These studies provide direct evidence for a crucial involvement of IgG Fc±FcgR interaction in glomerular recruitment of macrophages and following induction of anti-GBM glomerulonephritis in WKY rats.
Introduction
Anti-glomerular basement membrane (GBM) glomerulonephritis induced by the administration of a small dose (25 ml/ 100 g body wt) of anti-GBM antibody is characterized by glomerular accumulation of CD8 + T cells and macrophages, followed by crescentic formation (1) . This model is comparable with anti-GBM antibody-mediated crescentic glomerulonephritis in humans, which progresses to renal failure rapidly. To develop therapeutic methods for the crescentic glomerulonephritis, its pathogenesis needs to be understood. Our previous studies provided evidence for crucial roles of CD8 + T cells in the glomerular accumulation of macrophages, which were then presumed to injure glomerular structure and functions (1, 2) . Later on, roles of leukocyte adhesion molecules and chemokines in the development of this model were demonstrated (2±10). Although the glomerulonephritis is initiated by the binding of anti-GBM antibody to GBM, it is unclear how the in®ltrates are accumulated in the glomeruli after anti-GBM antibody binding. One of the possible mechanisms is immune adherence of leukocytes through interaction between the Fc portion of anti-GBM antibody and Fcg receptors (FcgR) expressed on the surface of the in®ltrating cells.
Three distinct types of receptors for IgG have been de®ned: FcgR1 (CD64) is the high-af®nity receptor for IgG and FcgR2 (CD32)/FcgR3 (CD16) are the low-af®nity receptors. These FcgR bind to the Fc portion of IgG molecule in the form of immune complexes, leading to the activation of various FcgRexpressing cells such as granulocytes, monocytes, macrophages, NK cells and subtypes of T cells (11±15). These cells express each FcgR subtype at different intensities and change the expression levels under in¯ammatory or pathological conditions (16±21). The roles of FcR in various in¯ammatory diseases have been veri®ed by using FcgRde®cient mice. FcR g chain knockout mice, which exhibited no expression of FcgR1, 2 and 3, failed to induce IgG-mediated endocytosis by macrophages. FcgR were also shown to play crucial roles in antibody-mediated hypersensitivity and immune complex-mediated hypersensitivity (16±19, 22, 23) . Recent works demonstrated that FcgR-de®cient mice were resistant to nephrotoxic glomerulonephritis, indicating a critical role for FcgR in the induction of murine glomerulonephritis (24, 25) . On the other hand, autoimmune glomerulonephritis occurred in FcgR-de®cient MRL/lpr mice as in wild-type MRL/lpr mice, indicating that the nephritis was FcgR independent (26) .
Since roles for FcgR in the initiation of the crescentic glomerulonephritis of WKY rats had not been elucidated, we examined the involvement of FcgR in this glomerulonephritis model and found a pivotal role for these receptors in the glomerular recruitment of macrophages, crescent formation and glomerular injury.
Methods

Animals
Animals used in this work were inbred male WKY rats (Charles River, Kanagawa, Japan), 200±250 g body wt, aged 12±16 weeks old.
Preparation of rabbit anti-GBM IgG and F(ab¢) 2 Partially puri®ed IgG was prepared from rabbit anti-GBM serum by 50% ammonium sulfate fractionation, followed by DEAE±cellulose column chromatography. IgG was further puri®ed by gel ®ltration on a Superdex 200 pg column using an AKTAexplorer 10S protein puri®cation system (Amersham Pharmacia Biotech, Piscataway, NJ). F(ab¢) 2 fragment was generated from the partially puri®ed IgG fraction by incubation with immobilized pepsin [ImmunoPure F(ab¢) 2 preparation kit; Pierce, Rockford, IL] as described in the manufacturer's instructions. The F(ab¢) 2 fragments were separated from undigested IgG and other proteolytic fragments by gel ®ltration on Superdex 200 pg. The puri®ed IgG and F(ab¢) 2 fragment showed apparent homogeneity on SDS±PAGE gel stained with Coomassie brilliant blue R-250.
Induction of anti-GBM glomerulonephritis
Rats were injected with the intact IgG at different doses (3.0, 1.5 and 0.75 mg/kg body wt, ®ve rats each). As we usually inject with 250 ml of anti-GBM antisera (containing 3.25 mg IgG)/kg body wt (4), the injected IgG doses in the present study were roughly equivalent to the amount of anti-GBM antisera used for the induction of anti-GBM glomerulonephritis in WKY rats. The ability to induce the glomerulonephritis was compared between intact IgG (1.5 mg/kg body wt, n = 5) and the F(ab¢) 2 fragment (0.75 mg/kg; the same molar dose as 1.5 mg intact IgG/kg, n = 5). The animals were sacri®ced at day 10 after the antibody injection. Urine specimens were collected on days 1, 4, 6 and 10 by housing animals in metabolic cages for 24 h. Urinary protein was estimated by using a protein assay kit (Nippon Bio-Rad, Tokyo, Japan).
Binding ef®ciency of intact IgG or F(ab¢) 2 of the anti-GBM antibody to GBM was examined by immuno¯uorescence microscopy. Rats were sacri®ced at 1 h, and days 4, 6 and 10 after intact IgG or F(ab¢) 2 antibody injection. Kidney slices were snap-frozen in n-hexane at ±70°C and sectioned in a cryostat. The cryostat sections (3 mm thick) were stained with uorescein-conjugated af®nity-puri®ed anti-rabbit IgG F(ab¢) 2 (Rockland Immunochemicals, Gilbertsville, PA).
Histological examination by light microscopy and immunohistochemistry
Kidney specimens were ®xed with methyl Carnoy's ®xative, and embedded in paraf®n for light microscopic examination and immunohistochemistry. The sections for light microscopy were stained with periodic acid±Schiff. mAb against rat CD8 and ED1 (Dainippon Seiyaku, Tokyo, Japan) were used for staining of in®ltrating CD8 + cells and macrophages respectively. To examine any involvement of platelets in the pathogenesis, they were immunolocalized in the kidneys using mouse monoclonal IgG antibody against rat platelet, PL-1 (kindly provided by Dr E. de Heer, Leiden University, The Netherlands). The numbers of immunostained cells were counted on >100 glomeruli in each kidney and expressed per glomerular cross-section. Rat FcgR2-bearing cells were immunostained with a mouse anti-rat CD32 mAb (BD PharMingen, San Diego, CA) in cryostat sections of frozen kidney samples.
Detection of glomerular mRNA for FcgR1, 2 and 3
Glomeruli were isolated from the renal cortex by a standard sieving method (27) . Total cellular RNA was extracted from the isolated glomeruli homogenized using a modi®ed guanidine thiocyanate method (TRIzol; Gibco/BRL, Grand Island, NY). Ribonuclease protection assay was performed for the detection of FcgR expression in the glomeruli. FcgR1 (178 bp), 2 (249 bp) and 3 (289 bp) cDNA were ampli®ed from the glomerular RNA obtained from rats 10 days after anti-GBM antibody injection by PCR with speci®c primers according to the sequences available in the GenBank database (AF143186, X73371 and M64369). Sense primers used for ampli®cation of FcgR1, 2 and 3 fragments were as follows: 5¢-CGGGATCCCTTGCAGCCTCCATGGGTCAG-3¢, 5¢-CGGGA-TCCCGAGTCTCATGCAGGTCTTCC-3¢ and 5¢-GGAATTC-ATGTGTCCAAGCCTGTCACC-3¢ respectively; and antisense primers were 5¢-CTGTCACCGCTTATGTCCACCCTTAAGG-3¢, 5¢-GAGGTCTGGAGAGTTGACCACCTTAAGG-3¢ and 5¢-CGAAGAAAAGTCGGTGTGGCCTAGGGC-3¢ respectively. As the sequence for rat FcgR1 was not available, the primers were designed to the regions of mouse FcgR1 sequence with the highest homology to human FcgR1 sequence. The ampli®ed PCR product was 87% homologous to the mouse FcgR1 DNA sequence. The FcgR1, 2 and 3 cDNA fragments were subcloned in pBluescript SK+ vectors and then linearized at the 5¢ ends to use as templates for preparation of 32 P-labeled antisense cRNA probes. Ten micrograms of total glomerular RNA was hybridized with a mixture of 32 P-labeled antisense cRNA probes (1 Q 10 5 c.p.m.) for each FcgR mRNA and GAPDH overnight at 45°C. Unhybridized cRNA probes were digested with ribonuclease T1 (120 U/ml; Gibco/BRL, Gaithersburg, MD) and ribonuclease A (4 mg/ml; Boehringer Mannheim, Tokyo, Japan) for 1 h at 30°C. The ribonucleases were then digested with proteinase K (500 mg/ml; Promega, Madison, WI) for 30 min at 37°C. After phenol:chloroform extraction and sodium acetate:ethanol precipitation the hybridized RNA probes were denatured at 95°C for 5 min and electrophoresed on a 6% polyacrylamide gel. Detection and analysis of bands were performed by phosphor-imaging techniques using the Molecular Imager FX (Bio-Rad, Hercules, CA). The data was represented as a ratio of speci®c mRNA:GAPDH mRNA to verify the constant quantity of mRNA in each sample.
Blocking of FcgR by heat-aggregated IgG (HAIgG)
HAIgG was prepared as described previously (28, 29) . Brie¯y, rat IgG was extracted from normal rat serum by 33% ammonium sulfate precipitation and heated at 63°C for 30 min. Resulting aggregates were ultracentrifuged at 10,000 g for 90 min to obtain the soluble fraction of HAIgG. Then, the soluble HAIgG was diluted in PBS and used in the experiment. Rats were injected with HAIgG (n = 5) and unaggregated rat IgG (n = 5) at a dose of 50 mg/100g body wt i.v. 30 min before the injection with anti-GBM antibody. Boost injections of HAIgG and unaggregated rat IgG were made on days 2 and 4 after the administration of anti-GBM antibody, and animals were sacri®ced on day 5.
Depletion of CD8 + cells
CD8 + cells were depleted from the circulation by administrating mAb against rat CD8 (MRC-OX8, 28 mg of g-globulin/kg body wt i.p. and 6 mg/kg i.v.) at two different time points of this glomerulonephritis model. One group of rats (pre-treated group, n = 20) was given the anti-CD8 antibody 2 days before the administration of 25 ml/100 g body wt of anti-GBM antibody as described in our previous studies (1,2), where we demonstrated that CD8 + cells in the circulation, spleen, cervical lymph node and thymus were completely depleted by this MRC-OX8 administration protocol, and the depletion was maintained for nearly 10 days. The other group of rats (posttreated group, n = 10) was given the antibody 3 days after anti-GBM antibody administration. As a control, rats were injected with irrelevant mAb and anti-GBM antibody or untreated. The animals from the pre-treated and control group were sacri®ced at days 1, 3, 7 and 14, and the posttreated group animals were sacri®ced at days 7 and 14 (®ve rats at each time point) for histological examination and RNA isolation from the glomeruli.
Urine specimens were collected on days 1, 3, 7 and 14 by housing animals in metabolic cages for 24 h. Urinary protein was estimated by using a protein assay kit (Nippon Bio-Rad).
Flow cytometry analysis
Flow cytometry was employed to examine FcgR2-bearing leukocytes obtained from the glomeruli and spleens of rats with anti-GBM glomerulonephritis. Glomeruli isolated from the renal cortices were disintegrated using a stainless mesh (30) . Then, leukocytes were isolated by centrifugation on 45% Percoll solution and stained with different combinations of antibodies: FITC-conjugated mouse anti-rat CD32 (clone D34-485) mAb, R-phycoerythrin (PE)-conjugated mouse anti-rat CD8 mAb (clone OX-8), PE-conjugated mouse anti-rat CD11b/c mAb (clone OX-42) and PE-conjugated mouse anti-rat CD4 mAb (clone OX-35). All antibodies were obtained from BD PharMingen (San Diego, CA). Stained cells were analyzed by two-color¯ow cytometry using a FACScan (Becton Dickinson Immunocytometry System, San Jose, CA).
Statistical analysis
Statistical evaluations were performed using the Mann± Whitney test (data meet the requirements for using the test). Analysis was performed with the use of Prism 3.0 for Windows (GraphPad, San Diego, CA). Data were considered statistically signi®cant at P < 0.05. All statistical tests were two-sided.
Results
Binding of anti-GBM antibody to the GBM
Both intact IgG (1.5 mg/kg) and the F(ab¢) 2 fraction (0.75 mg/ kg) of rabbit anti-GBM antibody were localized by immunouorescence microscopy along the GBM in a linear pattern at 1 h after injection (Fig. 1A and B) . No signi®cant difference in the intensity and distribution of rabbit IgG staining was observed between these groups throughout the experiment up to day 10 ( Fig. 2A and B) . No deposition of rat IgG was found in the glomeruli until day 5, and a faint but signi®cant signal was observed at day 7 and later after the anti-GBM antibody injection (Fig. 2C and D) . The intensity of immunouorescence for rat IgG was much weaker than that for rabbit IgG.
Induction of anti-GBM glomerulonephritis by intact IgG and F(ab¢) 2 of anti-GBM antibody
Although the binding of both IgG and F(ab¢) 2 fractions of antibody to GBM was nearly identical, anti-GBM glomerulonephritis was induced only in animals injected with intact IgG at day 10, and was characterized by hypercellular glomeruli with proteinaceous material deposition and crescent formation (Fig. 1C) . Immunohistochemical analysis revealed a signi®-cant number of CD8 + T cells (5.0 T 0.8 cells/glomerular cross-section, mean T SD, P < 0.01) and ED1 + macrophages (27.4 T 3.4 cells/glomerular cross-section, P < 0.01) in the glomeruli of intact IgG-injected rats ( Fig. 1E and G) . High levels of proteinuria also con®rmed the induction of anti-GBM glomerulonephritis (Fig. 3) . In contrast, no apparent glomerular histological changes, glomerular in®ltration of CD8 + T cells and ED1 + macrophages or proteinuria were observed in the F(ab¢) 2 -injected animals (Fig. 1D, F and H) . Considerable numbers of platelets were detected in the glomerular capillaries, but not in the crescentic lesions. In addition, the number and density of platelets in the glomeruli were almost the same as those detected in the interstitial capillaries (data not shown).
Expression of mRNA for FcgR in the glomeruli of rats from two experimental groups Expression of FcgR1, 2 and 3 mRNA was detected in the glomeruli of rats injected with intact anti-GBM IgG, but not in .00 (FcgR3) respectively in the group injected with the anti-GBM sera. The histological glomerular changes and the amounts of protein excreted in the urine were also almost identical in rats given anti-GBM antibody IgG at 1.5 or 3.0 mg/kg and in rats given anti-GBM antisera of 250 ml/kg (data not shown).
Blocking of FcgR by HAIgG
Control animals given unaggregated rat IgG + anti-GBM antibody exhibited high levels of proteinuria at day 5. In contrast, animals given HAIgG + anti-GBM antibody demonstrated a signi®cant reduction in protein excretion in the urine (Fig. 5) . Rabbit anti-GBM antibody was localized by immuno¯uores-cence microscopy along the GBM in a linear pattern in both groups at day 5 after injection. No signi®cant difference in the intensity of staining was observed between the two groups ( Fig. 2E and F) . The marked endocapillary hypercellularity and crescent formation induced in the control group rats were reduced in rats treated with HAIgG. The frequency of glomeruli with crescent formation was decreased from 76.8 T 3.5% in the control rats to 30 T 9.7% (P < 0.01) in the HAIgG-treated rats. Accumulation of CD8 + T cells and ED1 + macrophages was observed in the glomeruli of the control rats (Fig. 6A and B) . The numbers of macrophages detected in the glomeruli were signi®cantly decreased by the HAIgG treatment from 26.4 T 3.4 to 15.8 T 3.0 cells/ glomerular cross-section (P < 0.01), while that of CD8 + T cells was unaffected (4.7 T 1.1 versus 3.9 T 0.8 cells/ glomerular cross-section, P = 0.24) (Fig. 6C and D) .
The expression of mRNA for all three types of FcgR in the glomeruli was signi®cantly decreased by the HAIgG treatment: FcgR1:GAPDH mRNA ratio from 0.163 T 0.002 to 0.081 T 0.001 (P < 0.01), FcgR2:GAPDH mRNA ratio from 0.604 T 0.004 to 0.261 T 0.002 (P < 0.01) and FcgR3:GAPDH mRNA ratio from 0.402 T 0.003 to 0.214 T 0.002 (P < 0.01). 
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The decrease was also demonstrated in the cortices: FcgR1:GAPDH mRNA ratio from 0.065 T 0.006 to 0.046 T 0.002 (P < 0.01), FcgR2:GAPDH mRNA ratio from 0.085 T 0.003 to 0.064 T 0.005 (P < 0.01) and FcgR3:GAPDH mRNA ratio from 0.089 T 0.009 to 0.054 T 0.007 (P < 0.01) (Fig. 7) .
Effect of CD8 + cell depletion on FcgR expression
Glomerular hypercellularity caused by the accumulation of CD8 + T cells (4.5 T 1.7 cells/glomerular cross-section) and ED1 + macrophages (25.3 T 6.0 cells/glomerular crosssection) was found in the rats 7 days after anti-GBM antibody administration ( Fig. 8A and B) . In contrast, glomerular accumulation of CD8 + T cells was negligible (0.0 T 0.0 cells/ glomerular cross-section, P < 0.01) and that of macrophages (14.4 T 4.2 cells/glomerular cross-section, P < 0.01) was signi®cantly reduced by anti-CD8 antibody administration before anti-GBM antibody injection (Fig. 8C and D) . Through treatment with anti-CD8 antibody after anti-GBM antibody injection, the numbers of CD8 + T cells and ED1 + macrophages were also signi®cantly reduced in the glomeruli (0.1 T 0.0, P << 0.01 and 10.6 T 3.0, P < 0.01 respectively) ( Fig. 8E  and F) .
Excretion of urinary protein was almost completely suppressed in animals treated with anti-CD8 antibody before anti-GBM antibody injection (Fig. 9) . In contrast, the amount of urinary protein was unaffected by day 7 in animals given anti-CD8 antibody after anti-GBM antibody injection. However, urinary protein excretion was signi®cantly decreased at day 14 in these rats (208.5 T 50.2 versus 109.5 T 13.1 mg/day, P = 0.02) (Fig. 9) .
Glomerular expression of mRNA for all three types of FcgR gradually increased during the time course of anti-GBM glomerulonephritis, reached a plateau at day 3 and noticeably decreased at day 14 ( Fig. 10) . By administration of anti-CD8 antibody before anti-GBM antibody injection, expression of mRNA for FcgR1 and FcgR3 became faint, and FcgR2 expression was undetectable in the glomeruli until day 7. However, expression of all FcgR greatly increased in the glomeruli at day 14, which corresponds with the in¯ux of CD8 + T cells and ED1 + macrophages into the glomeruli at this time point as detected by immunohistochemical staining. While intense mRNA expression for all FcgR was demonstrated in the glomeruli at day 7 in animals treated with anti-CD8 antibody after anti-GBM antibody injection, expression of FcgR1 and 3 was obviously decreased, and that of FcgR2 was undetectable at day 14 ( Fig. 10) .
Flow cytometric analysis of leukocytes accumulating in the glomeruli
Immunostaining of frozen kidney cross-sections revealed that the number and distribution of FcgR2 + cells was comparable to those of ED1 + macrophages. In addition, FcgR2 staining was clearly observed in giant cells, which were apparently transformed from macrophages since they were ED1 + . These results bring us to the conclusion that FcgR2 is expressed by in®ltrating macrophages (Fig. 11A and B) .
To identify the exact type of FcgR2-bearing immune cells in the glomeruli, leukocytes isolated from glomeruli were stained with different combinations of antibodies and examined bȳ ow cytometry. The results showed that nearly equal proportions (~10%) of glomerular in®ltrates were CD4 + T cells and Fig. 7 . The mRNA expression of three types of FcgR in the renal cortex and glomeruli of rats isolated from the control group (unaggregated rat IgG + anti-GBM antibody, lanes 2±6 and 12), and the group treated with HAIgG (lanes 7±11 and 13) and normal glomeruli (lane 1). Fig. 8 . CD8 + T cell (A, C and E) and ED1 + macrophage (B, D and F) accumulation at day 7 after injection of anti-GBM antibody in glomeruli of control anti-GBM glomerulonephritis rats (A and B), antirat CD8 mAb pre-treated rats (C and D) and post-treated rats (E and F).
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at Pennsylvania State University on February 23, 2013 http://intimm.oxfordjournals.org/ Downloaded from CD8 + T cells, and that no expression of FcgR2 was detected on both CD4 + T cells and CD8 + T cells. In contrast, macrophages detected as CD 11b/c-bearing cells expressed FcgR2 (Fig. 11C±E) .
Discussion
Anti-GBM glomerulonephritis in WKY rats, initiated by a single injection with a small dose of anti-GBM antibody, is characterized by the predominant in®ltration of monocytes/macrophages and considerable accumulation of CD8 + T cells, and by the high frequency of glomerular crescent formation. The respective involvement of cell-mediated and humoral immunity in the development of this model is still indistinct. The present study was designed to examine the role of FcgR for the anti-GBM IgG antibody in the development of the crescentic glomerulonephritis model, which has not been clearly established in previous studies on this model.
In the current study we demonstrated that crescentic glomerulonephritis was induced only in animals injected with intact IgG of anti-GBM antibody, but not in animals injected with F(ab¢) 2 fractions of anti-GBM antibody, in spite of the equal binding of them to GBM. The gradual increase of expression of FcgR1, 2 and 3 mRNA during the time course of the disease was parallel to the progress of the disease. The observation suggested the signi®cance of these molecules in this model. To corroborate these results we performed in vivo blocking of FcgR by administering HAIgG. In a previous study, macrophage accumulation and subsequent glomerular injury in an experimental anti-GBM glomerulonephritis model in rabbits were demonstrated to be dependent on the Fc portion of the disease-initiating IgG molecule (31) . As HAIgG is a highaf®nity ligand for FcgR (28, 32) , its injections were expected to block all FcgR types of leukocytes in experimental animals and to elucidate the roles of these receptors in anti-GBM glomerulonephritis. The study showed a signi®cant amelioration of this model by FcgR blocking, suggesting that pathological changes and urinary protein excretion are dependent on the immune adherence of in®ltrating cells to heterologous antibody planted along the GBM through FcgR. The immune adherence may be mediated by binding between the complement receptors of leukocytes and the complement components activated by the immune complex in this model. However, we recently demonstrated no effects of decomplementation by cobra venom administration to rats on the (1); untreated anti-GBM group: day 1 (2), 3 (3), 7 (4) and 14 (5); anti-CD8 antibody pre-treated group: day 1 (6), 3 (7), 7 (8) and 14 (9); and anti-CD8 antibody post-treated group: day 7 (10) and 14 (11) . However, these data leave undecided the following questions: which type of FcgR is important and which type of in®ltrating cells express the FcgR? Previously, the macrophage was shown to be a major cell type accumulating in the glomeruli and crescentic lesions, and one of the most important mediators of glomerular injury and crescent formation (34, 35) . Furthermore, the crucial role of CD8 + T cells in the induction of the glomerulonephritis was demonstrated by almost complete suppression of the glomerular changes and injury in CD8 + T cell-depleted rats (1,2,36 ). The severity of glomerulonephritis, in®ltration by T cells and macrophages, and, particularly, the formation of crescents was greatly reduced by the treatment of experimental animals with anti-CD8 mAb (1,2,36 ). We assumed a linkage between CD8 + T cells and FcgR expression, leading to the progression of glomerulonephritis. To clarify this linkage, we examined FcgR expression in the glomeruli of anti-GBM glomerulonephritis rats in a CD8 + T cell-depleted condition. This experiment demonstrated that expression of mRNA for FcgR1 and 3 was signi®cantly decreased, but had not become null in the glomeruli, where no CD8 + T cells and a substantial number of macrophages were detected. The decrease of FcgR expression was associated with the decrease of macrophages accumulating to the glomeruli. These facts may indicate that these glomerular FcgR were expressed on the macrophages. On the other hand, the observation that FcgR2 expression was undetectable in the glomeruli of CD8 + T cell-depleted rats may indicate that FcgR2 are also expressed on the CD8 + T cells as well as macrophages. However,¯ow cytometry analysis of leukocytes isolated from glomeruli of anti-GBM glomerulonephritis rats showed that cells expressing FcgR2 were restricted to macrophages, but not to CD8 + T cells. Immunohistochemistry also showed FcgR2 immunoreactivity in a close association with ED1 + staining. In addition, glomerular accumulation of CD8 + T cells was not affected by HAIgG treatment in the present study. It has been reported that the cell-surface expression of FcgR is up-regulated by various agents, including such cytokines as IFN-g and IL-10 (37±40). CD8 + T cells could be the source of the cytokines which up-regulate the expression of FcgR on the surface of in®ltrating macrophages. Thus, our results support the data that macrophages are the major population of FcgR-bearing cells in the glomeruli of this model and CD8 + T cells stimulate expression of FcgR, especially FcgR2 in macrophages in the glomeruli. The role of other FcgR-bearing cells, such as mast cells or platelets, in this model is considered to be minor since no glomerular accumulation of mast cells has been shown in this model. Although considerable numbers of platelets were detected by immunostaining in the glomerular capillaries, similar numbers of platelets were also observed in the glomeruli of normal rat kidneys or interstitial capillaries. Therefore, both mast cells and platelets may not essentially contribute to the induction of this model, although we could not neglect the possibility of their minor participation.
Taken together, the present study proposes the following initiation mechanism of anti-GBM glomerulonephritis in WKY rats. At the beginning the heterologous anti-GBM antibody binds to GBM and attracts macrophages through the interaction between the IgG Fc portion of the antibody and FcgR on their surface. Macrophages begin to accumulate in glomeruli of this model from day 1 after the injection of anti-GBM antibody and their number increases during the time course of the disease (1). Rat antibody against rabbit IgG produced at the late phase binds to the rabbit anti-GBM antibody on GBM at day 5 after anti-GBM antibody injection, which was demonstrated by immuno¯uorescence microscopy. The rat anti-rabbit IgG antibody should also contribute to the macrophage accumulation at the late phase. The distribution of macrophages in glomeruli at the late phase better corresponded with the deposition of rat IgG rather than that of rabbit IgG, which also supports this suggestion.
The recognition of the Fc portion of anti-GBM antibody by FcgR should stimulate the macrophages to produce and release pro-in¯ammatory cytokines and chemokines, such as tumor necrosis factor, IL-1 and MCP-1 as described previously (1,2,4). Our previous study also showed that this model was CD8 + T cell dependent, and glomerular accumulation of CD8 + T cells was mediated through interaction between ICAM-1 and LFA-1 (1,3). Cytokines released from macrophages might stimulate induction of ICAM-1 expression on endothelial cells and activate LFA-1 on CD8 + T cells in the glomeruli. However, it is unclear how CD8 + T cells play a key role in this model. Up-regulation of IFN-g in the glomeruli of this model was demonstrated in our previous study (2) , suggesting that CD8 + T cells and CD4 + T cells might be stimulated by another cytokine, such as IL-12, released from macrophages in the glomeruli. IL-12 is a cytokine known to stimulate CD4 + T cells to differentiate to T h 1, and also stimulates CD8 + T cells and CD4 + T cells to produce IFN-g (2,17). Then, IFN-g could further activate macrophages to express FcgR and to promote macrophage-mediated glomerular injury as delayed-type hypersensitivity.
In conclusion, this is the ®rst study providing direct evidence of the crucial participation and role of FcgR in the initiation of anti-GBM antibody-induced crescentic glomerulonephritis in WKY rats and the recruitment of macrophages to the glomeruli. Although the type of FcgR mostly contributing to the progression of this glomerulonephritis has not yet been identi®ed, the important role of the FcgR-mediated immune adherence was clari®ed in the macrophage accumulation in this model.
